#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia refractory Ischaemic stroke ROHHAD syndrome Lymphoma Hepato-lenticular degeneration T-cell lymphoma Transitional cell carcinoma Osteosarcoma HER2 gene amplification Ventricular tachycardia Peripheral T-cell lymphoma unspecified Neutropenia Malignant melanoma Von Hippel-Lindau disease Pelizaeus-Merzbacher disease More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Basic Information Myxofibrosarcoma – Treatment Idiopathic pulmonary fibrosis – Trials in Disease Wiskott-Aldrich syndrome – Trials in Disease Lymphatic malformation – Trials in Disease Osteosarcoma – Trials in Disease Advanced systemic mastocytosis – Trials in Disease Hepatoblastoma – Diagnostics Basal cell naevus syndrome – Treatment Langerhans’ cell histiocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Izaflortaucipir (18F) Baxdrostat Olive Oil, Refined Bms-986288 L-Lysine Hydrochloride Filgotinib Bi 1819479 Leriglitazone R3R01 Pimavanserin Tartrate Intestifix Mitazalimab Ethanol (96 Per Cent) Quinine Dihydrochloride Flecainide Acetate Anselamimab Etifoxine Hydrochloride Warfarin Sodium Avatrombopag Bemarituzumab More therapies…

    Learn about Your Condition

    Spinal cord injury Colon cancer stage II Oral herpes Endometriosis Hypochondroplasia Relapsing multiple sclerosis Periarthritis Atopic keratoconjunctivitis Optic atrophy Graft versus host disease Cardiac failure congestive Vomiting Acquired haemophilia Viral myocarditis Meningococcal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Safety of Mercaptamine with Standard Therapy for Hospitalized COVID-19 Pneumonia Patients Not Requiring High Oxygen Flows

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Respiratory tract infection
    • Respiratory tract infection viral
    • COVID-19
    Investigated Drugs:
    • Mercaptamine
    Italy

  • Study on the Effectiveness of Valganciclovir for Patients with Glioblastoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Valganciclovir
    Norway Sweden

  • A study of the effects of nirmatrelvir, ritonavir, and rosuvastatin in healthy adult participants

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Ritonavir
    • Rosuvastatin Calcium
    • Nirmatrelvir
    Belgium

  • Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Chloride
    Belgium Estonia Finland France Germany Italy +1

  • A study to evaluate the taste of sisunatovir and denatonium benzoate in healthy adults for the treatment of respiratory syncytial virus (RSV)

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Sisunatovir
    Belgium

  • A Study of Brelovitug Compared to Delayed Treatment in Patients with Chronic Hepatitis Delta Infection

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bjt-778
    Belgium Bulgaria Hungary
Previous Page
1 … 22 23 24 25 26 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!